Orthopaedic Manifestations of Mucopolysaccharidosis.
- 1Department of Orthopedics, Seattle Children's Hospital, Seattle, WA, USA.
- 2Department of Orthopedics, Coloraco Children's Hospital, Denver, CO, USA.
Abstract
Mucopolysaccharidosis (MPS) is a group of lysosomal storage disorders caused by deficiencies in cellular enzymes, resulting in the accumulation of glycosaminoglycans. The orthopaedic clinician and multidisciplinary team must recognize a wide array of pathology due to accumulation within bones, joints, the tenosynovium, and growth plates. The sequelae can include growth deficiency, carpal tunnel compression, trigger finger, hip dysplasia, limb malalignment, C1-2 instability, and thoracolumbar kyphosis with possible spinal cord compression or tracheal obstruction. This current concept review aims to summarize pertinent orthopaedic findings for patients with known MPS. (1)Mucopolysaccharidosis (MPS) is a family of lysosomal storage disorders that result in glycosaminoglycan accumulation, leading to progressive tissue deterioration.(2)In the undiagnosed patient, phenotypic features include coarse facies, macroglossia, flat nasal bridge, short stature, limb deformities, and joint pathology.(3)The skeletal manifestations of MPS can include hip dysplasia, genu valgum, ankle valgus, thoracolumbar gibbus deformity, and cervical spine stenosis and instability with risk of spinal cord compression.(4)In the upper extremity, carpal tunnel syndrome and the development of trigger fingers require close surveillance by physical exam, ultrasound, and electrodiagnostic studies.(5)Longitudinal surveillance for these patients is warranted for orthopaedic and nonorthopaedic sequelae, with judicious airway and spinal cord monitoring for operative procedures.(6)Timely operative intervention is imperative, especially for spinal cord compression and for the timing of deformity corrections.
Related
- Early Recognition of Patients with Neuronopathic Forms of Mucopolysaccharidosis Type II in Clinical Practice
- Induction of Oral Immune Tolerance Enables Sequential AAV9/AAV8 Gene Therapy in Mucopolysaccharidosis IVA
- Synthesis of the Endogenous Non-Reducing End Heparan Sulfate Disaccharides for Newborn Screening and Diagnosis of Mucopolysaccharidosis types I and II
- Structural damage of the cervical spinal cord within and beyond the maximal compression area in mucopolysaccharidosis types I and VI
- Metabolomic profiling in treated mucopolysaccharidosis IH reveals candidate biomarkers and adjunctive therapeutic pathways
BibTeX
@article{tremonti2026orthopaedic,
title = {{Orthopaedic Manifestations of Mucopolysaccharidosis.}},
author = {Chris Tremonti and Elle Bui and Klane K White and Suzanne Steinman},
journal = {Journal of the Pediatric Orthopaedic Society of North America},
year = {2026},
month = sep,
doi = {10.1016/j.jposna.2026.100459},
url = {https://europepmc.org/article/MED/42997816},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Orthopaedic Manifestations of Mucopolysaccharidosis.
AU - Chris Tremonti
AU - Elle Bui
AU - Klane K White
AU - Suzanne Steinman
PY - 2026
DA - 2026/09/18
JO - Journal of the Pediatric Orthopaedic Society of North America
DO - 10.1016/j.jposna.2026.100459
UR - https://europepmc.org/article/MED/42997816
AB - Mucopolysaccharidosis (MPS) is a group of lysosomal storage disorders caused by deficiencies in cellular enzymes, resulting in the accumulation of glycosaminoglycans. The orthopaedic clinician and multidisciplinary team must recognize a wide array of pathology due to accumulation within bones, joints, the tenosynovium, and growth plates. The sequelae can include growth deficiency, carpal tunnel compression, trigger finger, hip dysplasia, limb malalignment, C1-2 instability, and thoracolumbar kyphosis with possible spinal cord compression or tracheal obstruction. This current concept review aims to summarize pertinent orthopaedic findings for patients with known MPS. (1)Mucopolysaccharidosis (MPS) is a family of lysosomal storage disorders that result in glycosaminoglycan accumulation, leading to progressive tissue deterioration.(2)In the undiagnosed patient, phenotypic features include coarse facies, macroglossia, flat nasal bridge, short stature, limb deformities, and joint pathology.(3)The skeletal manifestations of MPS can include hip dysplasia, genu valgum, ankle valgus, thoracolumbar gibbus deformity, and cervical spine stenosis and instability with risk of spinal cord compression.(4)In the upper extremity, carpal tunnel syndrome and the development of trigger fingers require close surveillance by physical exam, ultrasound, and electrodiagnostic studies.(5)Longitudinal surveillance for these patients is warranted for orthopaedic and nonorthopaedic sequelae, with judicious airway and spinal cord monitoring for operative procedures.(6)Timely operative intervention is imperative, especially for spinal cord compression and for the timing of deformity corrections.
SN - 2768-2765
ER -